Method of treating cancer with HDAC inhibitors

Details for Australian Patent Application No. 2004266169 (hide)

International Classifications

Event Publications

6 April 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Mar 2006

6 April 2006 PCT application entered the National Phase

PCT publication WO2005/018578 Priority application(s): WO2005/018578

3 May 2007 Application Accepted

Published as AU-B-2004266169

2 August 2007 Assignment before Grant

Sloan-Kettering Institute for Cancer Research; Anton Pharma, Inc. The application has been assigned to Sloan-Kettering Institute for Cancer Research; Merck HDAC Research, LLC

30 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.